1. Innovation in Cancer Precision Medicine through Digital Transformation
Cancer genomic medicine has recently begun in Japan, cancer treatment based on genomic information involves detecting genetic abnormalities in cancer cell to select treatment options matched to cancer cell characteristics. Optimal treatment for the patient is investigated by a multidisciplinary team of experts known as a Molecular Tumor Board (MTB). With new relationships between treatment options and genetic abnormalities being found every day, discussion of the latest candidate treatment options by MTB is important for improving patient outcomes.
But heavy workloads of MTB members are required for tasks such as the highly time-consuming searches for the latest treatment options done by physicians. To solve this issue, Hitachi has developed an MTB assistance service through a collaborative creation project with the Personalized Medicine Center of Tohoku University Hospital that provides candidate treatment options and decrease the burden of physicians.
Hitachi will utilize genomic analysis information and artificial intelligence (AI) technologies to create solutions for big data analysis of genomic medicine. By providing solutions that enable physicians to make efficient clinical decisions on personalized treatment options, Hitachi will contribute to bring advanced cancer precision medicine to as many patients as possible.